TKT to Present At SG Cowen's Fifth Annual Global Health Care Conference

TKT to Present At SG Cowen's Fifth Annual Global Health Care
Conference 


CAMBRIDGE, Mass., Nov. 9  /PRNewswire-FirstCall/ -- Transkaryotic Therapies,
Inc. (NASDAQ:TKTX) today announced that the company will present at SG Cowen's
5th Annual Global Health Care Conference being held in Geneva, Switzerland,
November 16-17, 2004.  Michael J. Astrue, President and Chief Executive Officer
will present an overview of TKT's business activities and product pipeline at
10:20 a.m. Central European Time on Tuesday, November 16, 2004.  A live audio
webcast of this presentation will be available at http://www.tktx.com/ on TKT's
Investor Information website under the Events category.  A replay will be
available for approximately 30 days after the webcast.

About TKT

Transkaryotic Therapies, Inc. is a biopharmaceutical company primarily focused
on researching, developing and commercializing treatments for rare diseases
caused by protein deficiencies.  Within this focus, the company markets
Replagal(TM), an enzyme replacement therapy for Fabry disease, and is
developing treatments for Hunter syndrome and Gaucher disease.  In addition to
its focus on rare diseases, TKT intends to commercialize Dynepo(TM), its Gene-
Activated(R) erythropoietin product for anemia related to kidney disease, in
the European Union.  TKT was founded in 1988 and is headquartered in Cambridge,
Massachusetts, with additional operations in Europe, Canada and South America. 
Additional information about TKT is available on the company's website at
http://www.tktx.com/.

Gene-Activated(R) is a registered trademark and Replagal(TM) is a trademark of
Transkaryotic Therapies, Inc.  Dynepo(TM) is a trademark of Sanofi-Aventis SA.

  Contact:
   Daniella M. Lutz
   Corporate Communications Manager
   [phone]


http://www.newscom.com/cgi-bin/prnh/19990913/TKTLOGO

http://photoarchive.ap.org/

DATASOURCE: Transkaryotic Therapies, Inc.



CONTACT:  Daniella M. Lutz, Corporate Communications Manager of TKT, +1-

617-349-0205



Web site:  http://www.tktx.com/



Company News On-Call:  http://www.prnewswire.com/comp/120657.html

Copyright